Supernus Pharmaceuticals, Inc. (SUPN)

50.70 -1.10 (-2.11%) USD  |  NASDAQ  |  Jan 15, 13:55
More

Supernus Pharmaceuticals Rent and Landing Expense (Quarterly)

Rent and Landing Expense (Quarterly) Chart

View Rent and Landing Expense (Quarterly) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Rent and Landing Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Rent and Landing Expense (Quarterly) Range, Past 5 Years

View Rent and Landing Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Rent and Landing Expense (Quarterly) Benchmarks

View Rent and Landing Expense (Quarterly) Benchmarks
Start Trial
Amphastar Pharmaceuticals, Inc. --
BridgeBio Pharma, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Assembly Biosciences, Inc. --
Viking Therapeutics, Inc. Upgrade